[HTML][HTML] New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort

O Koren, V Patel, R Naami, E Naami… - Frontiers in …, 2022 - frontiersin.org
Objective To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …

[PDF][PDF] New adverse coronary events in valve-in-valve TAVR and native TAVR—A-year matched cohort

O Koren, V Patel, R Naami, E Naami, T Nagasaka… - researchgate.net
Objective: To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …

[HTML][HTML] New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort

O Koren, V Patel, R Naami, E Naami… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Objective To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …

New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort

O Koren, V Patel, R Naami, E Naami… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …

[PDF][PDF] New adverse coronary events in valve-in-valve TAVR and native TAVR—A-year matched cohort

O Koren, V Patel, R Naami, E Naami, T Nagasaka… - academia.edu
Objective: To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …

New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort.

O Koren, V Patel, R Naami, E Naami… - Frontiers in …, 2022 - europepmc.org
Objective To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …

[PDF][PDF] New adverse coronary events in valve-in-valve TAVR and native TAVR—A-year matched cohort

O Koren, V Patel, R Naami, E Naami, T Nagasaka… - academia.edu
Objective: To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR) …